For in vitro diagnostic use. Others Elecsys Anti-HBc II IVD Elecsys® Anti-HBc II CPS_000437 09 014 918 160 9 014 918 160 09014918160 9014918160 09014918160 Anti-HBc G2 Elecsys cobas e 100 V2 Elecsys® Anti-HBc II 07613336203606 Reagents, kits 100 tests cobas e 411/601/602 true 07 394 764 190 7 394 764 190 07394764190 7394764190 07394764190 Anti-HBc G2 Elecsys cobas e 200 Elecsys Anti-HBc II 04015630946235 Reagents, kits 200 tests cobas e 411/601/602 true 09 014 926 192 9 014 926 192 09014926192 9014926192 09014926192 Anti-HBc G2 Elecsys E2G 10x300 Elecsys Anti-HBc II 07613336224168 Reagents, kits 10x300 tests cobas e 402/801 true 09 014 926 190 9 014 926 190 09014926190 9014926190 09014926190 Anti-HBc G2 Elecsys E2G 300 V2 Elecsys Anti-HBc II 07613336171929 Reagents, kits 300 tests cobas e 402/801 true 07 026 790 160 7 026 790 160 07026790160 7026790160 07026790160 Anti-HBc G2 Elecsys E2G 300 Elecsys Anti-HBc II 07613336153925 Reagents, kits 300 tests cobas e 402/801 true 09 014 918 190 9 014 918 190 09014918190 9014918190 09014918190 Anti-HBc G2 Elecsys cobas e 100 V2 Elecsys Anti-HBc II 07613336171912 Reagents, kits 100 tests cobas e 411/601/602 true 09 109 463 190 9 109 463 190 09109463190 9109463190 09109463190 a-HBC Gen.2 Elecsys cobas e 200 V2 Elecsys Anti-HBc II 07613336198872 Reagents, kits 200 tests cobas e 411/601/602 true 09 014 926 162 9 014 926 162 09014926162 9014926162 09014926162 Anti-HBc G2 Elecsys E2G 10 x 300 Anti-HBc G2 Elecsys E2G 10 x 300 07613336183106 Reagents, kits 10 x 300 tests cobas pro serology solution true 09 014 926 160 9 014 926 160 09014926160 9014926160 09014926160 Anti-HBc G2 Elecsys E2G 300 V2 Elecsys® Anti-HBc II 07613336203613 Reagents, kits 300 tests cobas e 801 undefined 07 374 160 160 7 374 160 160 07374160160 7374160160 07374160160 Anti-HBc G2 Elecsys cobas e 100 Elecsys Anti-HBc II 07613336142295 Reagents, kits 100 tests cobas e 411/601/602 true 07 374 160 190 7 374 160 190 07374160190 7374160190 07374160190 Anti-HBc G2 Elecsys cobas e 100 Elecsys Anti-HBc II 04015630946228 Reagents, kits 100 tests cobas e 411/601/602 true 07 026 790 190 7 026 790 190 07026790190 7026790190 07026790190 Anti-HBc G2 Elecsys E2G 300 Elecsys Anti-HBc II 04015630946686 Reagents, kits 300 tests cobas e 402/801 true 09014918501 Elecsys Anti-HBc II en 2 FF00000006DDA30E FF0000000574210E 09014918160 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of total antibodies to hepatitis B core antigen (anti‑HBc) in human serum and plasma (lithium heparin, sodium citrate, potassium EDTA) in adult patients with the symptoms of hepatitis or who may be at risk for hepatitis B virus (HBV) infection. The detection of total anti‑HBc is indicative of a laboratory diagnosis for HBV infection. Further HBV serological marker testing is required to define the specific disease state. The immunoassay's performance has not been established for the monitoring of HBV disease or therapy. The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e immunoassay analyzers. en 07394764500 Elecsys Anti-HBc II en 4 FF00000004A1F00E FF000000016F700E 07394764190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of IgG and IgM antibodies to the hepatitis B core antigen in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en 09014926503 Elecsys Anti-HBc II en 1 FF000000064BA00E FF000000064BA00E 09014926192 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of IgG and IgM antibodies to the hepatitis B core antigen in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 09014926500 Elecsys Anti-HBc II en 1 FF0000000499D80E FF0000000499D80E 09014926190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of IgG and IgM antibodies to the hepatitis B core antigen in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07026790501 Elecsys Anti-HBc II en 1 FF0000000270D20E FF0000000270D20E 07026790160 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of total antibodies to hepatitis B core antigen (anti‑HBc) in human serum and plasma (lithium heparin, sodium citrate, potassium EDTA) in adult patients with the symptoms of hepatitis or who may be at risk for hepatitis B virus (HBV) infection. The detection of total anti‑HBc is indicative of a laboratory diagnosis for HBV infection. Further HBV serological marker testing is required to define the specific disease state. The immunoassay's performance has not been established for the monitoring of HBV disease or therapy. The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e immunoassay analyzers. en 09014918500 Elecsys Anti-HBc II en 1 FF000000049A3C0E FF000000049A3C0E 09014918190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of IgG and IgM antibodies to the hepatitis B core antigen in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 09109463500 Elecsys Anti-HBc II en 1 FF000000049A430E FF000000049A430E 09109463190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of IgG and IgM antibodies to the hepatitis B core antigen in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 09014926502 Elecsys Anti-HBc II en 3 FF0000000730F20E FF0000000659EE0E 09014926162 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useElecsys Anti-HBc II is an in vitro immunoassay for the qualitative detection of antibodies to hepatitis B core antigen (anti‑HBc) in human serum and plasma. Elecsys Anti-HBc II is intended to screen individual human donors, including volunteer donors of whole blood and blood components. The assay is also intended to be used to screen organ, tissue and cell donors, when donor samples are obtained while the donor’s heart is still beating. It is not intended for use on cord blood specimens.The electrochemiluminescence immunoassay “ECLIA” is intended for use with cobas pro serology solution equipped with cobas e 801 analytical unit. en 09014926501 Elecsys Anti-HBc II en 2 FF000000062B270E FF0000000571D30E 09014926160 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of total antibodies to hepatitis B core antigen (anti‑HBc) in human serum and plasma (lithium heparin, sodium citrate, potassium EDTA) in adult patients with the symptoms of hepatitis or who may be at risk for hepatitis B virus (HBV) infection. The detection of total anti‑HBc is indicative of a laboratory diagnosis for HBV infection. Further HBV serological marker testing is required to define the specific disease state. The immunoassay's performance has not been established for the monitoring of HBV disease or therapy. The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e immunoassay analyzers. en 09014926501 Elecsys Anti-HBc II en 3 FF00000007219F0E FF000000062B270E 09014926160 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of total antibodies to hepatitis B core antigen (anti‑HBc) in human serum and plasma (lithium heparin, sodium citrate, potassium EDTA) in adult patients with the symptoms of hepatitis or who may be at risk for hepatitis B virus (HBV) infection. The detection of total anti‑HBc is indicative of a laboratory diagnosis for HBV infection. Further HBV serological marker testing is required to define the specific disease state. The immunoassay's performance has not been established for the monitoring of HBV disease or therapy. The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en ms_07374160160_USA Elecsys Anti-HBc II en 2 FF0000000257580E FF00000002399D0E 07374160160 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of total antibodies to hepatitis B core antigen (anti‑HBc) in human serum and plasma (lithium heparin, sodium citrate, potassium EDTA) in adult patients with the symptoms of hepatitis or who may be at risk for hepatitis B virus (HBV) infection. The detection of total anti‑HBc is indicative of a laboratory diagnosis for HBV infection. Further HBV serological marker testing is required to define the specific disease state. The immunoassay's performance has not been established for the monitoring of HBV disease or therapy. The electrochemiluminescence immunoassay “ECLIA” is intended for use on the MODULAR ANALYTICS E170, cobas e 601 and cobas e 602 immunoassay analyzers. en ms_07374160160_USA Elecsys Anti-HBc II en 2 FF0000000257570E FF0000000239A00E 07374160160 618 cobas e 411 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of total antibodies to hepatitis B core antigen (anti‑HBc) in human serum and plasma (lithium heparin, sodium citrate, potassium EDTA) in adult patients with the symptoms of hepatitis or who may be at risk for hepatitis B virus (HBV) infection. The detection of total anti‑HBc is indicative of a laboratory diagnosis for HBV infection. Further HBV serological marker testing is required to define the specific disease state. The immunoassay's performance has not been established for the monitoring of HBV disease or therapy. The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e 411 immunoassay analyzer. en 07374160500 Elecsys Anti-HBc II en 4 FF00000004A1DD0E FF000000016F6E0E 07374160190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of IgG and IgM antibodies to the hepatitis B core antigen in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en 07026790500 Elecsys Anti-HBc II en 4 FF00000004A1F70E FF00000000E8730E 07026790190 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of IgG and IgM antibodies to the hepatitis B core antigen in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e 801 immunoassay analyzer. en

User Profile

Select your user profile

Elecsys^® Anti-HBc II

Overview

Detailed Specifications

Ordering Information

Compatible Instruments

Technical Documents

Access important product documentation including relevant certificates and other resources.